Agile Therapeutics Inc. (AGRX)

NASDAQ: AGRX · Real-Time Price · USD

1.51

0.05 (3.42%)

At close: Aug 22, 2024, 7:58 PM

Agile Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	2.56M	5.25M	19.14M	14.46M	34.48M	7.85M	35.95M	48.75M
Short-Term Investments	n/a	n/a	n/a	40.01M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	238K	2.01M	2.01M	1.9M	177K	18K	18K	18K
Receivables	3.39M	3.38M	1.53M	865K	n/a	n/a	n/a	n/a
Inventory	2.74M	1.33M	966K	1.00	n/a	n/a	n/a	n/a
Other Current Assets	402K	1.4M	2.28M	1.45M	840K	607K	762K	2.77M
Total Current Assets	9.53M	11.36M	23.93M	56.78M	35.32M	8.46M	36.71M	51.52M
Property-Plant & Equipment	487K	872K	13.4M	14.38M	14.04M	13.92M	13.86M	12.33M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	725K	2.88M	15.41M	16.28M	14.22M	13.93M	13.88M	12.35M
Total Assets	10.26M	14.24M	39.33M	73.06M	49.54M	22.39M	50.59M	63.87M
Account Payables	9.57M	7.73M	8.71M	3.87M	1.82M	875K	2.78M	2.05M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	852K	n/a
Short-Term Debt	1.71M	1.75M	17.01M	138K	172K	n/a	10.61M	5.1M
Other Current Liabilities	832K	514K	1.91M	1.56M	1.8M	621K	244K	921K
Total Current Liabilities	20.78M	13.39M	29.28M	7.35M	3.79M	2.22M	14.27M	10.68M
Long-Term Debt	n/a	n/a	n/a	16.38M	n/a	n/a	n/a	10.9M
Other Long-Term Liabilities	5.7M	5.93M	5.36M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	5.8M	6.4M	784K	16.38M	n/a	n/a	n/a	10.9M
Total Liabilities	26.57M	19.79M	30.06M	23.73M	3.79M	2.22M	14.27M	21.58M
Total Debt	2.17M	2.21M	17.79M	16.52M	172K	n/a	10.61M	16M
Common Stock	4K	4K	12K	9K	7K	3K	3K	3K
Retained Earnings	-423.17M	-408.7M	-387.12M	-312.22M	-260.37M	-241.55M	-221.77M	-193.47M
Comprehensive Income	n/a	n/a	n/a	3K	n/a	-369K	-346K	-323K
Shareholders Equity	-16.32M	-5.54M	9.27M	49.33M	45.74M	20.17M	36.32M	42.29M
Total Investments	n/a	n/a	n/a	40.01M	n/a	n/a	n/a	n/a